117 related articles for article (PubMed ID: 21669217)
1. Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential.
Yousuf SK; Majeed R; Ahmad M; Sangwan Pl; Purnima B; Saxsena AK; Suri KA; Mukherjee D; Taneja SC
Steroids; 2011; 76(10-11):1213-22. PubMed ID: 21669217
[TBL] [Abstract][Full Text] [Related]
2. Withanolides from Withania aristata and their cytotoxic activity.
Llanos GG; Araujo LM; Jiménez IA; Moujir LM; Vázquez JT; Bazzocchi IL
Steroids; 2010 Dec; 75(12):974-81. PubMed ID: 20542049
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of withanolides isolated from Tunisian Datura metel L.
Bellila A; Tremblay C; Pichette A; Marzouk B; Mshvildadze V; Lavoie S; Legault J
Phytochemistry; 2011 Nov; 72(16):2031-6. PubMed ID: 21851957
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells.
Llanos GG; Araujo LM; Jiménez IA; Moujir LM; Bazzocchi IL
Eur J Med Chem; 2012 Aug; 54():499-511. PubMed ID: 22705001
[TBL] [Abstract][Full Text] [Related]
5. Azide-alkyne cycloaddition en route to novel 1H-1,2,3-triazole tethered isatin conjugates with in vitro cytotoxic evaluation.
Singh P; Sharma P; Anand A; Bedi PM; Kaur T; Saxena AK; Kumar V
Eur J Med Chem; 2012 Sep; 55():455-61. PubMed ID: 22818042
[TBL] [Abstract][Full Text] [Related]
6. Withanolides from the rhizomes of Dioscorea japonica and their cytotoxicity.
Kim KH; Choi SU; Choi SZ; Son MW; Lee KR
J Agric Food Chem; 2011 Jul; 59(13):6980-4. PubMed ID: 21661726
[TBL] [Abstract][Full Text] [Related]
7. Chemistry of withaferin-A: chemo, regio, and stereoselective synthesis of novel spiro-pyrrolizidino-oxindole adducts of withaferin-A via one-pot three-component [3+2] azomethine ylide cycloaddition and their cytotoxicity evaluation.
Bharitkar YP; Kanhar S; Suneel N; Mondal SK; Hazra A; Mondal NB
Mol Divers; 2015 May; 19(2):251-61. PubMed ID: 25749788
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.
Kumar D; Narayanam MK; Chang KH; Shah K
Chem Biol Drug Des; 2011 Mar; 77(3):182-8. PubMed ID: 21251232
[TBL] [Abstract][Full Text] [Related]
10. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel steroidal 17α-triazolyl derivatives via Cu(I)-catalyzed azide-alkyne cycloaddition, and an evaluation of their cytotoxic activity in vitro.
Frank É; Molnár J; Zupkó I; Kádár Z; Wölfling J
Steroids; 2011; 76(10-11):1141-8. PubMed ID: 21600229
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of withanolides against human breast cancer cell lines.
Machin RP; Veleiro AS; Nicotra VE; Oberti JC; M Padrón J
J Nat Prod; 2010 May; 73(5):966-8. PubMed ID: 20438092
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities.
Li Z; Gu Z; Yin K; Zhang R; Deng Q; Xiang J
Eur J Med Chem; 2009 Nov; 44(11):4716-20. PubMed ID: 19560842
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxic evaluation, and DNA binding of novel thiazolo[5,4-b]quinoline derivatives.
Loza-Mejía MA; Maldonado-Hernández K; Rodríguez-Hernández F; Rodríguez-Sotres R; González-Sánchez I; Quintero A; Solano JD; Lira-Rocha A
Bioorg Med Chem; 2008 Feb; 16(3):1142-9. PubMed ID: 18035542
[TBL] [Abstract][Full Text] [Related]
16. An efficient one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives as anti-cancer agents.
Yan SJ; Liu YJ; Chen YL; Liu L; Lin J
Bioorg Med Chem Lett; 2010 Sep; 20(17):5225-8. PubMed ID: 20655212
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
18. Efficient synthesis and in vitro cytostatic activity of 4-substituted triazolyl-nucleosides.
El Akri K; Bougrin K; Balzarini J; Faraj A; Benhida R
Bioorg Med Chem Lett; 2007 Dec; 17(23):6656-9. PubMed ID: 17931862
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
20. 1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII.
Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2005 May; 60(5):367-75. PubMed ID: 15910810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]